Last updated: 2026-10-14 14:58:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
iRadimed Corporation (IRMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $89.76, with a market capitalisation of $1.14B and a P/E ratio of 49.72. Over the past 52 weeks, its price has ranged from $71.34 to $107.90. This page covers its latest market performance, valuation, price trends and company information.
$1.14B | |
$89.61 | |
$107.90 | |
$6.26 | |
$89.65 | |
12.06K | |
123.83K | |
49.72 | |
$107.90 | |
$71.34 | |
1.38% | |
-- |
iRadimed Corporation (IRMD) is currently trading at $89.76 as of 2026-10-14 14:57:00, up 0.12% ($0.11) from the previous close of $89.65
During today's regular trading session, IRMD has traded between $6.26 and $107.90, with a trading volume of 12.06K shares. The current price is near the upper end of today's range.
Over the past seven days, iRadimed Corporation (IRMD) moved from $86.47 to $89.76, representing a gain of 3.80% ($3.29).
The stock traded between $83.84 and $90.46 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 108.60 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 50.4%
IRMD is currently trading at $89.76, placing it 50.4% of the way from its 52-week low of $71.34 to its 52-week high of $107.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 166 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of iRadimed Corporation (IRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.